Stock SANDUPHQ6 SANDU PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Sandu Pharmaceuticals Limited

Equities

SANDUPHQ6

INE751D01014

Delayed Bombay S.E.
Other stock markets
 02:28:50 2024-06-12 EDT 		5-day change 1st Jan Change
60.06 INR +0.40% Intraday chart for Sandu Pharmaceuticals Limited +2.53% -11.81%
06-05 Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
06-05 Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Sandu Pharmaceuticals Limited Appoints Shri Vijay Kajrekar as Chief Financial Officer
CI
Sandu Pharmaceuticals Limited Announces Executive Changes
CI
Sandu Pharmaceuticals Board Mulls CFO Appointment
MT
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Sandu Pharmaceuticals CFO to Step Down in December
MT
Sandu Pharmaceuticals Limited Announces CFO Changes
CI
Sandu Pharmaceuticals' Consolidated Net Profit Slips in Fiscal Q2
MT
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Sandu Pharmaceuticals Limited Approves Change in Directorate
CI
Sandu Pharmaceuticals Shuts Goa, India Plant for Renovation
MT
Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31St March 2023
CI
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Sandu Pharmaceuticals Expands Partnership with Vietnam's Bach Ma Van Xuan; Shares Jump 3%
MT
Sandu Pharmaceuticals Limited Enters into Memorandum of Understanding with Bach Ma Van Xuan Pharmaceuticals
CI
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Sandu Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2022
CI
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31 March 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SANDUPHQ6 Stock
  4. News Sandu Pharmaceuticals Limited